Healius confident PCR tests will stay even in endemic stage
Lucas BairdReporter
Pathology and imaging business Healius has posted a 44.2 per cent surge in revenue in the half-year to $1.34 billion and more than trebled its net profit amid a COVID-19 testing boom.
Even as the country shifts to a “living with COVID-19” position where restrictions and testing requirements are less onerous, chief executive Malcolm Parmenter says there will still be a base load of virus testing required.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles